4 Results for "

HBV mutant

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "HBV mutant" in MCE Product Catalog:

  • Targets Recommended:
2
2 Cited Publications
Cat. No.: HY-100028
CAS No.: 211364-06-6
Purity:  98.39%
Target:  

HBV DNA/RNA Synthesis

Research Areas:  

Infection Cancer

AT-130, a phenylpropenamide derivative, is a potent hepatitis B virus (HBV) replication non-nucleoside inhibitor. AT-130 inhibits the viral DNA synthesis with an EC50 of 0.13 μM. AT-130 inhibits both wt and mutant HBVs. AT-130 has anti-HBV activity in hepatoma cells .
loading...
    loading...
Cat. No.: HY-122209
CAS No.: 330461-34-2
Target:  

HBV

Research Areas:  

Infection

DVR-01 is a HBV inhibitor with EC50 values of 1.7 and 1.6 μM in AML12HBV10 and HepDES19 cells, respectively. DVR-01 shows antiviral activity against drug-resistant HBV mutants with EC50s of 2.403-3.273 μM. DVR-01 can be used for the research of HBV infection and related diseases .
loading...
    loading...
Cat. No.: HY-114956
CAS No.: 300669-68-5
Target:  

HBV

Research Areas:  

Infection

AT-61 is a non nucleoside HBV replication inhibitor. AT-61 prevents the capsid formation of pre genomic RNA, resulting in the production of empty capsids. AT-61 has the activity of drug-resistant mutant strains. AT-61 can be used for research on hepatitis B virus infection .
loading...
    loading...
Cat. No.: HY-100028R
CAS No.: 211364-06-6
Research Areas:  

Infection Cancer

AT-130 (Standard) is the analytical standard of AT-130 (HY-100028). This product is intended for research and analytical applications. AT-130, a phenylpropenamide derivative, is a potent hepatitis B virus (HBV) replication non-nucleoside inhibitor. AT-130 inhibits the viral DNA synthesis with an EC50 of 0.13 μM. AT-130 inhibits both wt and mutant HBVs. AT-130 has anti-HBV activity in hepatoma cells .
loading...
    loading...